Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-02-04 4:17 pm Purchase | 13G | VIVEVE MED INC PAR $ VIVE | Hudson Bay Capital Management LP | 258,064 2.38% | 17,075 (+7.09%) | View |
2022-01-18 11:21 am Unchanged | 13G | VIVEVE MED INC PAR $ VIVE | Empery Asset Management LP | 1,029,411 4.99% | 0 (Unchanged) | View |
2021-02-16 11:21 am Purchase | 13G | VIVEVE MED INC PAR $ VIVE | Alyeska Investment Group L.P. | 163,000 0.2% | 163,000 (New Position) | View |
2021-02-10 7:01 pm Purchase | 13G | VIVEVE MED INC PAR $ VIVE | Hudson Bay Capital Management LP | 240,989 9.99% | 240,989 (New Position) | View |
2021-01-19 09:58 am Purchase | 13G | VIVEVE MED INC PAR $ VIVE | Empery Asset Management LP | 1,029,411 9.96% | 1,029,411 (New Position) | View |
2021-01-15 6:21 pm Purchase | 13G | VIVEVE MED INC PAR $ VIVE | Lincoln Park Capital Fund LLC | 701,000 9.99% | 701,000 (New Position) | View |
2020-02-14 1:38 pm Sale | 13G | VIVEVE MED INC VIVE | RTW INVESTMENTS LP | 0 0% | -4,480,565 (Position Closed) | View |
2020-02-14 09:26 am Purchase | 13G | VIVEVE MED INC PAR $ VIVE | Alyeska Investment Group L.P. | 244,811 6.1% | 244,811 (New Position) | View |
2020-02-13 3:42 pm Purchase | 13G | VIVEVE MED INC PAR $ VIVE | CR Group L.P. | 6,986,473 67.2% | 6,986,473 (New Position) | View |
2020-02-13 12:10 pm Sale | 13G | VIVEVE MED INC VIVE | Hood River Capital Management LLC | 0 0% | -3,337,811 (Position Closed) | View |
2020-02-11 07:03 am Unchanged | 13G | VIVEVE MED INC PAR $ VIVE | UBS Group AG UBS | 0 0% | 0 (Unchanged) | View |
2020-02-10 3:13 pm Sale | 13G | VIVEVE MED INC PAR $ VIVE | CVI Investments Inc. | 179,397 4.9% | -67,847 (-27.44%) | View |
2020-02-07 3:43 pm Purchase | 13G | VIVEVE MED INC PAR $ VIVE | Hudson Bay Capital Management LP | 446,555 9.99% | 446,555 (New Position) | View |
2019-12-02 10:25 am Purchase | 13G | VIVEVE MED INC PAR $ VIVE | CVI Investments Inc. | 247,244 9.9% | 247,244 (New Position) | View |
2019-09-10 5:00 pm Sale | 13G | VIVEVE MED INC VIVE | Nantahala Capital Management LLC | 0 0% | -6,581,465 (Position Closed) | View |
2019-08-01 06:01 am Unchanged | 13G | VIVEVE MED INC VIVE | Nantahala Capital Management LLC | 6,581,465 14.2% | 0 (Unchanged) | View |
2019-07-23 5:22 pm Sale | 13D | VIVEVE MED INC VIVE | Stonepine Capital Management LLC | 57,802 0.1% | -3,849,711 (-98.52%) | View |
2019-06-26 5:12 pm Purchase | 13D | VIVEVE MED INC VIVE | 5AM Ventures II LP | 807,837 1.7% | 807,837 (New Position) | View |
2019-05-03 4:01 pm Unchanged | 13D | VIVEVE MED INC VIVE | Nantahala Capital Management LLC | 6,581,465 14.2% | 0 (Unchanged) | View |